Oxygen-rich chemotherapyviamodified Abraxane to inhibit the growth and metastasis of triple-negative breast cancer
Author:
Affiliation:
1. State Key Laboratory of Pharmaceutical Biotechnology
2. Medical School and School of life science
3. Nanjing University
4. Nanjing 210093
5. China
Abstract
Oxygen-rich chemotherapyviaMnO2modified Abraxane® for inhibiting growth and metastasis of triple negative breast cancer.
Funder
National Natural Science Foundation of China
State Key Laboratory of Natural Medicines
Publisher
Royal Society of Chemistry (RSC)
Subject
General Materials Science,Biomedical Engineering
Link
http://pubs.rsc.org/en/content/articlepdf/2019/BM/C8BM00753E
Reference48 articles.
1. Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence
2. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype
3. Triple-negative breast cancer: therapeutic options
4. Molecular alterations in triple-negative breast cancer—the road to new treatment strategies
5. ETNA (Evaluating Treatment with Neoadjuvant Abraxane) randomized phase III study comparing neoadjuvant nab-paclitaxel (nab-P) versus paclitaxel (P) both followed by anthracycline regimens in women with HER2-negative high-risk breast cancer: A MICHELANGO study.
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Mitochondrial metabolism blockade nanoadjuvant reversed immune-resistance microenvironment to sensitize albumin-bound paclitaxel-based chemo-immunotherapy;Acta Pharmaceutica Sinica B;2024-09
2. Manganese Dioxide-Based Nanomaterials for Medical Applications;ACS Biomaterials Science & Engineering;2024-04-08
3. Self‐Propelled Nanomotor for Cancer Precision Combination Therapy;Advanced Healthcare Materials;2024-02-07
4. The impact of tumor microenvironment: unraveling the role of physical cues in breast cancer progression;Cancer and Metastasis Reviews;2024-01-19
5. Integration of Manganese Dioxide‐Based Nanomaterials for Biomedical Applications;Advanced NanoBiomed Research;2022-12-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3